Protein kinase C beta relieves autism‐like behavior in EN2 knockout mice via upregulation of the FTO/PGC‐1α/UCP1 axis

Xingyu Song,Qibo Hu,Xiaoheng Xu,Wei Pan
DOI: https://doi.org/10.1002/jbt.23236
IF: 3.568
2022-10-16
Journal of Biochemical and Molecular Toxicology
Abstract:Increasing evidence suggests that disruption of neuron activity contributes to the autistic phenotype. Thus, we aimed in this study to explore the role of protein kinase C beta (PKCβ) in the regulation of neuron activity in an autism model. The expression of PKCβ in the microarray data of autism animal models was obtained from the Gene Expression Omnibus database. Then, mice with autism‐like behavior were prepared in EN2 knockout (−/−) mice. The interaction between PKCβ on fat mass and obesity‐associated protein (FTO) as well as between PGC‐1α and uncoupling protein 1 (UCP1) were characterized. The effect of FTO on the N6‐methyladenosine (m6A) modification level of proliferator‐activated receptor gamma coactivator 1‐alpha (PGC‐1α) was assayed. Following transfection of overexpressed PKCβ and/or silenced UCP1, effects of PKCβ and UCP1 in autism‐like behaviors in EN2−/− mice were analyzed. Results showed that PKCβ was downregulated in EN2−/− mouse brain tissues or neurons. PKCβ promoted the expression and stability of FTO, which downregulated the m6A modification level of PGC‐1α to promote its expression. Moreover, PGC‐1α positively targeted the expression of UCP1. PKCβ knockdown enhanced sociability and spatial exploration ability, and reduced neuron apoptosis in EN2−/− mouse models of autism, which was reversed by UCP1 overexpression. Collectively, PKCβ overexpression leads to activation of the FTO/m6A/PGC‐1α/UCP1 axis, thus inhibiting neuron apoptosis and providing neuroprotection in mice with autism‐like behavior.
biochemistry & molecular biology,toxicology
What problem does this paper attempt to address?